Sponsor / Institution

University of Colorado Anschutz Medical Center

Organization-level profile for a sponsor, institution, collaborator, or mixed-role entity. These profiles are separated from the primary industry company index when appropriate.

All Programs Therapeutics Devices

Open filtered programs

Programs

linked to organization

Strong Evidence

0 status confirmed

Details Checked

0 open data checks

Company / Institution Links

0 / 1

industry vs non-industry records

Competitive Density

Pipeline Velocity

Completion Signal

Programs by Stage

Phase 1/21

Trial / Program Status

Active1

Modality Mix

Small Molecule1

Indication Coverage

Age-Related Hearing Loss1

Hearing Loss1

Noise-Induced Hearing Loss1

Sensorineural Hearing Loss1

Program Types

Therapeutic1

Population Tags

adult1

age-related1

central-auditory-processing-disorder1

combination-study1

older-adult1

speech-in-noise1

Strong-Evidence Records

0 records

No strong-evidence records are linked to this organization yet.

Checked Records With Caveats

1 checked · 0 open checks

Colorado LOOT clemastine plus engineered sound CAPD study

Details checked

Small MoleculePhase 1/2Active

Clemastine fumarate combined with proprietary engineered sound stimulation, intended to drive remyelination of activated central auditory pathways for age-related central auditory processing disorder/hearing-in-noise deficits.

Data checks: institution-led-study, active-recruiting